Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular”

2,889 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,889 results

Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Not applicableStudy completedNCT01790958
What this trial is testing

Microcurrent Stimulation to Treat Macular Degeneration

Who this might be right for
Retinal DiseasesStargardt's DiseaseRetinitis Pigmentosa
Retina Institute of Hawaii 50
Not applicableStudy completedNCT06798285
What this trial is testing

Comparision of Retinal Function and Macular Structure After 27G Pars Plana Vitrectomy With Minimal Illuminiation

Who this might be right for
Epiretinal Membrane
Pomeranian Medical University Szczecin 40
Large-scale testing (Phase 3)UnknownNCT01083004
What this trial is testing

Brilliant Blue Versus Indocyanine Green

Who this might be right for
Macular PuckerMacular HoleVitreoretinal Surgery
University of Cologne 50
Testing effectiveness (Phase 2)Study completedNCT01136252
What this trial is testing

Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
Hospital Universitari Vall d'Hebron Research Institute 5
Early research (Phase 1)Study completedNCT00950638
What this trial is testing

ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration

Who this might be right for
Dry Age-Related Macular Degeneration
Ophthotech Corporation 47
Not applicableLooking for participantsNCT04847635
What this trial is testing

Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration

Who this might be right for
Macular Degeneration, SenileLaser Burn of RetinaMacular Degeneration Intermediate+1 more
Ospedale San Raffaele 50
Early research (Phase 1)Study completedNCT00346853
What this trial is testing

Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy

Who this might be right for
Macular Dystrophy, Corneal
University of Utah 10
Not applicableStudy completedNCT02279537
What this trial is testing

Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD

Who this might be right for
Wet Macular Degeneration
Bayer 593
Not applicableStudy completedNCT02645747
What this trial is testing

Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Bayer 126
Not applicableStudy completedNCT01568021
What this trial is testing

Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Retinal Vein OcclusionMacular Edema
Allergan 100
Not applicableStudy completedNCT04505306
What this trial is testing

Short-pulse Subthreshold vs Infrared Micropulse for Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Moorfields Eye Hospital Centre Abu Dhabi 113
Post-approval studies (Phase 4)Study completedNCT02305238
What this trial is testing

Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Bayer 288
Large-scale testing (Phase 3)Study completedNCT00470678
What this trial is testing

EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Macular Degeneration
Novartis 95
Early research (Phase 1)Study completedNCT05324592
What this trial is testing

Safety and Efficacy of 9MW0813 in Subjects With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Mabwell (Shanghai) Bioscience Co., Ltd. 24
Testing effectiveness (Phase 2)Looking for participantsNCT06659549
What this trial is testing

Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

Who this might be right for
Geographic Atrophy of the Macula
Galimedix Therapeutics Inc 110
Not applicableStudy completedNCT00548158
What this trial is testing

Effect of Pioglitazone Therapy for Type 2 Diabetes on Vision

Who this might be right for
Type 2 Diabetes
University of California, San Diego 19
Not applicableWithdrawnNCT05675917
What this trial is testing

MacuTest Website for Personalized AMD Risk Prediction and Prevention

Who this might be right for
Macular Degeneration
University Hospital, Bordeaux
Not applicableStudy completedNCT01442064
What this trial is testing

An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 608
Early research (Phase 1)Ended earlyNCT00102115
What this trial is testing

Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Light Sciences LLC 27
Load More Results